- Report
- August 2021
Global
From €3791EUR$3,990USD£3,250GBP
- Report
- October 2022
- 81 Pages
Global
From €3320EUR$3,495USD£2,847GBP
- Report
- March 2022
- 58 Pages
Global
From €3320EUR$3,495USD£2,847GBP
- Report
- November 2020
- 36 Pages
Global
From €3795EUR$3,995USD£3,254GBP
- Clinical Trials
- December 2019
- 154 Pages
Global
From €2375EUR$2,500USD£2,037GBP
- Drug Pipelines
- October 2020
- 811 Pages
Global
From €1900EUR$2,000USD£1,629GBP
- Report
- July 2022
- 80 Pages
Africa
From €3605EUR$3,795USD£3,092GBP
- Report
- July 2022
- 40 Pages
Saudi Arabia
From €2465EUR$2,595USD£2,114GBP
- Report
- July 2022
- 40 Pages
India
From €2465EUR$2,595USD£2,114GBP
- Report
- July 2023
- 133 Pages
China
From €1710EUR$1,800USD£1,466GBP
- Report
- July 2023
- 101 Pages
China
From €1710EUR$1,800USD£1,466GBP
- Report
- April 2023
- 109 Pages
Global
€3325EUR$3,500USD£2,851GBP
- Report
- September 2020
- 88 Pages
Global
From €3800EUR$4,000USD£3,259GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €475EUR$500USD£407GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €475EUR$500USD£407GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €475EUR$500USD£407GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €475EUR$500USD£407GBP
- Report
- January 2019
- 35 Pages
Global
From €950EUR$1,000USD£815GBP
- Report
- January 2019
- 35 Pages
Global
From €950EUR$1,000USD£815GBP
- Report
- January 2019
- 35 Pages
Global
From €950EUR$1,000USD£815GBP
The Asthma Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of medications used to treat asthma. Asthma is a chronic respiratory condition that affects the airways, causing difficulty breathing, coughing, and wheezing. Asthma drugs are designed to reduce inflammation in the airways, making it easier for patients to breathe. These drugs can be taken orally, inhaled, or injected, depending on the severity of the condition. Common asthma drugs include corticosteroids, bronchodilators, and leukotriene modifiers.
Some of the major companies in the Asthma Drugs market include GlaxoSmithKline, Merck & Co., Novartis, Pfizer, and Sanofi. These companies are involved in the research, development, and marketing of asthma drugs, as well as the production of generic versions of existing drugs. They also provide support services to patients, such as educational materials and access to specialists. Show Less Read more